Summary
Plasma concentrations of nitrazepam were measured by gas-liquid chromatography in: young healthy volunteers, in geriatric and psychiatric patients and in epileptic children. The disposition of nitrazepam was described in terms of a two-compartment open model. After a single oral dose of nitrazepam 5 mg the most prominent differences between the experimental groups were in the β-phase half-life-mean 29 h in the young volunteers and 40 h in geriatric patients, and in the apparent volume of distribution during the β-phase of 2.4 vs 4.8 l/kg. Total plasma clearance and the average steady state concentration in both groups were equal. The plasma level rose at a rate proportional to the β-phase half-life, and so, they were achieved more rapidly in the young than in the old subjects (3.5 vs 7.5 d). No change in steady-state level or in the half-life of nitrazepam were found during long term treatment, which indicates lack of enzyme induction or inhibition. In 95% of the epileptic children with a good to fair clinical response, the plasma concentration of nitrazepam was 40–180 ng/ml (mean 114 ng/ml). As all of the patients were on combined antiepileptic therapy, no attempt was made to correlate plasma level with therapeutic response.
Similar content being viewed by others
References
Andersen, T., Lingjaerde, O.: Nitrazepam as sleep-inducing agent. Br. J. Psychiatry115, 1393–1397 (1969)
Bender, A. D.: Pharmacologic aspects of aging. A survey of the effects of increasing age or drug activity in adults. J. Am. Geriatr. Soc.12, 114–134 (1964)
Castleden, C. M., Kaye, C. M., Parsons, R. L.: The effect of age on plasma levels of propranolol and practolol in man. Br. J. clin. Pharmacol.2, 303–306 (1975)
Castleden, C. M., George, C. F., Marcer, D., Hallet, C.: Increased sensitivity to nitrazepam in old age. Br. med. J.1977/I, 10–12
Chan, K., Kendall, M. J., Mitchard, M., Wells, W. D. E.: The effect of ageing on plasma pethidine concentration. Br. J. clin. Pharmacol.2, 297–302 (1975)
Chen, K. K., Brown-Robbins, E.: Influence of age of rabbits on the toxicity of oubain. J. Am. Pharm. Assoc.32, 61–62 (1943)
Edelman, J. S., Leibman, J.: Anatomy of body water and electrolytes. Am. J. Med.27, 256–277 (1959)
Evans, J. G., Jarvis, E. H.: Nitrazepam and the elderly. Br. med. J.1972/IV, 487
Haider, I.: A double-blind controlled trial of a non-barbiturate hypnotic, nitrazepam. Br. J. Psychiatry114, 337–343 (1968)
Hurwitz, N.: Predisposing factors in adverse reaction to drugs. Br. med. J.1969/I, 536–539
Irvine, R. E., Grove, J., Toseland, P. A., Trounce, J. R.: The effect of age on the hydroxylation of amylobarbitone sodium in man. Br. J. clin. Pharmacol.1, 41–43 (1974)
Jelliffe, R. W., Blankenhorn, D. H.: Improved method of digitalis therapy in patients with reduced renal function. Circulation36, Suppl. 2: 150 (1967)
Jori, A., DiSalle, E., Quadri, A.: Rate of aminopyrine disappearance from plasma in young and aged humans. Pharmacology8, 273–279 (1972)
Kangas, L.: Comparison of two gas-liquid chromatographic methods for plasma nitrazepam determination. J. Chromatogr.136, 259–270 (1977)
Kangas, L., Kanto, J., Syvälahti, E.: Plasma nitrazepam concentrations after an acute intake and their correlation to sedation and serum growth hormone levels. Acta pharmacol. toxicol.41, 65–73 (1977a)
Kangas, L., Kanto, J., Siirtola, T., Pekkarinen, A.: Cerebrospinal-Fluid Concentrations in Nitrazepam in man. Acta pharmacol. toxicol.41, 74–79 (1977b)
Kanto, J., Iisalo, E., Lehtinen, V., Salminen, J.: The concentrations of idazepam and its metabolites in the plasma after an acute and chronic administration. Psychopharmacologia (Berl.)36, 123–131 (1974)
van der Kleijn, E., Guelen, P. J. M., van Wijk, C. G. W. M., Baars, I., Vree, T. B.: Clinical pharmacokinetics of benzodiazepines, barbiturates and short chain fatty acids. In: Clinical pharmacokinetics. G. Levy (ed.), pp. 79–101. Buffalo, New York: American Pharmaceutical Association, Academy of Pharmaceutical Sciences, 1974
Klotz, U., Avant, G. R., Hoyumpa, A., Schenker, S., Wilkinson, G. R.: The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J. clin. Invest.55, 347–359 (1975)
Linnoila, M.: Drug interaction on psychomotor skills related to driving. Ann. Med. Exp. Biol. Fenn.51, 118–124 (1973)
Linnoila, M., Viukari, M.: Efficacy and side effects of nitrazepam and thioridazine as sleeping aids in psychiatric inpatients. Br. J. Psychiatry128, 566–569 (1976)
MIMS18, 50 (1976)
Morgan, H., Scott, D. F., Joyce, C. R. B.: The effects of four hypnotic drugs and placebo on normal subjects sleeping and dreaming at home. Br. J. Psychiatry117, 649–652 (1970)
Nation, R. L., Learoyd, B., Barber, J., Triggs, E. J.: The pharmacokinetics of chlormethiazole following intravenous administration in the aged. Europ. J. clin. Pharmacol.10, 407–415 (1976)
O'Malley, K., Crooks, J., Duke, E., Stevenson, I. H.: Effect of age and sex on human drug metabolism. Br. med. J.1971/III, 607–609
Rieder, J.: Plasma levels and derived pharmacokinetic characteristics of unchanged nitrazepam in man. Arzneim.-Forsch. (Drug Res.)23, 212–218 (1973)
Ritschel, W. A.: Angewandte Biopharmazie. Stuttgart: Wissenschaftliche Verlagsgesellschaft 1973
Rowland, M., Blaschke, T. F., Meffin, P. J., Williams, R. L.: Pharmacokinetics in disease states modifying hepatic and metabolic function. In: The effects of disease states on drug pharmacokinetics. L. Z. Benet (ed.), pp. 53–75. Washington: American Pharmaceutical Association, Academy of Pharmaceutical Sciences 1976
Saario, I., Linnoila, M., Mäki, M.: Interaction of drugs with alcohol on human psychomotor skills related to driving: effect of sleep deprivation or two week's treatment with hypnotics. J. clin. Pharmacol.15, 52–59 (1975)
Sellman, R., Kanto, J., Raijola, E., Pekkarinen, A.: Induction effect of diazepam on its own metabolism. Acta pharmacol. toxicol.37, 345–351 (1975)
Traeger, A.: Untersuchungen zum Einfluß des Lebensalters, der Schwangerschaft und der eingeschränkten Nierenfunktion auf die Pharmakokinetik ausgewählter Arzneimittel bei erstmaliger und wiederholter Applikation. Diss. Jena, 1975
Vestal, R. E., Norris, A. H., Tobin, J. D., Cohen, B. H., Shock, N. W., Andres, R.: Antipyrine metabolism in man: influence of age, alcohol, caffeine, and smoking. Clin. Pharmacol. Ther.18, 425–432 (1975)
Wilkinson, G. R., Shand, D. G.: A physiological approach to hepatic drug clearance. Clin. Pharmacol. Ther.18, 377–390 (1975)
Author information
Authors and Affiliations
Additional information
Supported by Orion Foundation, Helsinki, Finland
Rights and permissions
About this article
Cite this article
Kangas, L., Iisalo, E., Kanto, J. et al. Human pharmacokinetics of nitrazepam: Effect of age and diseases. Eur J Clin Pharmacol 15, 163–170 (1979). https://doi.org/10.1007/BF00563100
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00563100